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Does a biomedical research centre affect
patient care in local hospitals?
Catherine A Lichten1†, Grace Marsden2† , Alexandra Pollitt3, Vasiliki Kiparoglou4, Keith M Channon4 and Jon Sussex1*
Abstract
Background: Biomedical research can have impacts on patient care at research-active hospitals. We qualitatively
evaluated the impact of the Oxford Biomedical Research Centre (Oxford BRC), a university-hospital partnership,
on the effectiveness and efficiency of healthcare in local hospitals. Effectiveness and efficiency are conceptualised
in terms of impacts perceived by clinicians on the quality, quantity and costs of patient care they deliver.
Methods: First, we reviewed documentation from Oxford BRC and literature on the impact of research activity on patient
care. Second, we interviewed leaders of the Oxford BRC’s research to identify the direct and indirect impacts they expected
their activity would have on local hospitals. Third, this information was used to inform interviews with senior clinicians
responsible for patient care at Oxford’s acute hospitals to discover what impacts they observed from research generally and
from Oxford BRC’s research work specifically. We compared and contrasted the results from the two sets of interviews using
a qualitative approach. Finally, we identified themes emerging from the senior clinicians’ responses, and compared them
with an existing taxonomy of mechanisms through which quality of healthcare may be affected in research-active settings.
Results:We were able to interview 17 research leaders at the Oxford BRC and 19 senior clinicians at Oxford’s acute hospitals.
The research leaders identified a wide range of beneficial impacts that they expected might be felt at local hospitals as a
result of their research activity. They expected the impact of their research activity on patient care to be generally positive.
The senior clinicians responsible for patient care at those hospitals presented a more mixed picture, identifying many
positive impacts, but also a smaller number of negative impacts, from research activity, including that
of the Oxford BRC. We found the existing taxonomy of benefit types to be helpful in organising the findings, and
propose modifications to further improve its usefulness.
Conclusions: Impacts from research activity on the effectiveness and efficiency of patient care at the local acute hospitals,
as perceived by senior clinicians, were more often beneficial than harmful. The Oxford BRC contributed to those impacts.
Keywords: Research activity, Hospitals, Patient care, Impact
Background
Improving the translation of scientific discoveries into
health benefits for patients and the population in general
has long been an aim of government policy in the United
Kingdom and internationally. According to the Cooksey
review of United Kingdom health research funding [1],
there are two gaps in the translation of health research into
practice: the first is in translating basic and clinical research
into the development of new products, technologies and
approaches to the treatment of illness and health, and the
second is in implementing these products, technologies
and service approaches in clinical practice.
In England, direct manifestations of the policy aim to
improve research translation have been the creation of
the National Institute of Health Research (NIHR) in
April 2007, supported by the United Kingdom Govern-
ment’s Department of Health, and subsequent funding of
‘Biomedical Research Centres’ (BRCs) as well as Biomed-
ical Research Units, Collaborations for Leadership in
Applied Health Research and Care, Academic Health
Sciences Centres (AHSCs), and Academic Health Sciences
Networks. Each BRC is a partnership between a university
and a National Health Service (NHS) hospital organisa-
tion. A major explicit aim of BRCs is to “translate
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advances in biomedical research into benefits for patients”
[2] and thus address the first gap identified by the Cooksey
Review.
Outside the United Kingdom, several countries, in-
cluding Canada, the Netherlands, Singapore and the
United States of America, have developed collaborative
AHSC models linking academic institutions with
healthcare delivery systems [3]. Among other inter-
national efforts to promote translation, in the Unites
States in 2006, the National Institutes of Health intro-
duced the Clinical and Translation Science Awards
Program to address two main aspects of research trans-
lation: the advancement of discoveries from basic and
preclinical research into human studies, and the dis-
semination and adoption of best practices [4]. Housed
in the National Center for Advancing Translational
Sciences (established in 2011), the programme funds a
network of sites across the United States that provide
support in a range of relevant areas including infra-
structure, regulatory support, patient recruitment, re-
searcher training, and statistics expertise.
NIHR funding of NHS hospital–university partnerships
through the BRCs aims to bring together discovery science
capabilities and strengths (typically based in the university
partner) with clinical research platforms, personnel and
patients (typically based in the NHS hospital partner). In
this way, the NIHR BRCs form an important component
of the United Kingdom’s AHSCs, aligning with other
major centres based on partnerships between hospital and
university organisations internationally.
Biomedical research can have substantial and varied im-
pacts on patient care and on society more widely [5, 6]. A
perceptions audit of senior hospital executives and medical
school deans involved in the BRC scheme carried out 18
months after the establishment of the BRCs highlighted their
role in building capacity in translational research and
strengthening collaborative relationships between the NHS,
academia, industry and other stakeholders [7]. That study also
noted that it was too early to measure benefits (or otherwise)
for patients at the time. Several years on, an initial evaluation
of the impacts on patient care has become possible.
We report here our qualitative evaluation of the impact
of the NIHR Oxford Biomedical Research Centre (hereafter
Oxford BRC) on the effectiveness and efficiency of health-
care provided in local NHS hospitals. Effectiveness and
efficiency are conceptualised in our study in terms of
impacts perceived by clinicians on the quality and quantity
of patient care they deliver, alongside their perceptions of
the impacts on the costs of (resources used by) doing so.
Oxford BRC was one of the five large ‘comprehensive’
BRCs in England that have been funded by the NIHR since
April 2007 (there are, additionally, several other BRCs fo-
cused on narrower subsets of biomedical research). The
NIHR Oxford BRC is a partnership between the University
of Oxford and the Oxford University Hospitals NHS
Foundation Trust (hereafter OUH), which operates four
publicly owned acute teaching hospitals – three large
tertiary centre hospitals in Oxford and a small general acute
hospital in the town of Banbury. The University of Oxford
is a major university and conducts a large amount of
biomedical research, which provides the basis for the
Oxford BRC. OUH provides the full range of emergency
and non-emergency acute secondary hospital services for
the city of Oxford and the surrounding areas of Oxfordshire,
along with tertiary hospital services for a much wider region
across South-Central England. The University of Oxford
and OUH are partners in the Oxford Academic Health
Science Centre, a partnership that also includes Oxford
Brookes University and Oxford Health NHS Founda-
tion Trust, a neighbouring NHS hospital that provides
clinical services in mental health and community care,
and hosts an NIHR BRC focussing on mental health.
Oxford BRC conducts translational research within 14
research themes (RTs) and has also established seven
‘Working Groups’ (WGs) to address strategic prior-
ities that cross multiple RTs.
There is a growing literature on the effect on the
performance of healthcare providers if their clinical
staff are engaged in research. When research takes
place in a clinical setting, this may affect the research
itself – for example, by facilitating more effective or
efficient clinical trials [8] or in relation to the aspects
highlighted by Marjanovic et al. [7], namely improving
research relevance and prioritisation of research re-
sources, building capacity in translational research;
and strengthening collaborative relationships between
the NHS, academia, industry and other stakeholders. It
may also have an effect on the patient care provided within
that institution [9]. Research may have direct impacts by
bringing about changes to healthcare, like a new diagnostic
tool or treatment or a reorganisation of processes for
delivering care. It may also have indirect impacts through,
for example, changes to provision of equipment, training,
or changes in attitudes to research among staff.
While evidence has not been unanimous on the exist-
ence and nature of these impacts on patient care,
Hanney et al.’s [10] major review of the literature con-
cluded that there is indeed an overall positive association
between the engagement of individuals and healthcare
organisations in research and levels of healthcare per-
formance. The authors have helpfully developed a
taxonomy of five types of mechanism through which
such improvements might occur, set out in Box 1. These
mechanisms are in addition to any benefits derived
directly by patients as a result of their own participation
in clinical trials. We have compared our findings with
this taxonomy of mechanisms, which for brevity we refer
to as ‘the Hanney framework’ from here on.
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More recently, Ozdemir et al. [11] have reported posi-
tive and statistically significant associations implying that
research-active NHS hospitals in England have lower
risk-adjusted mortality for acute admissions, which per-
sisted after adjustment for staffing and other structural
factors. More recently still, Harding et al. [12] have
presented a systematic review of literature specifically
focused on associations between research culture in
healthcare organisations and their performance as care
providers. They find eight studies satisfying their criteria
(including [11] and overlapping with the broader review
by Hanney et al. [10]) and conclude that a “stronger
research culture appears to be associated with benefits to
patients, staff and the organisation”.
We note that the original definition of ‘absorptive cap-
acity’, coined by Cohen and Levinthal [13], was “the ability
of a firm to recognise the value of new, external information,
assimilate it, and apply it” and which was suggested to be
“largely a function of the firm’s level of prior related know-
ledge”. Following the lead of Hanney et al. [10], we interpret
this as having a broad application that can be extended be-
yond existing knowledge (the main example by Cohen and
Levinthal) to existing infrastructure.
Methods
Our research design is qualitative, which inevitably means
that we are not able to quantify any impacts found. We con-
sidered that a qualitative approach was essential to explore
the subtle nature and extent of any possible impacts amid
the numerous confounding factors that influence available
measures of care outcomes, and costs of care, at OUH.
To assess the impacts of the Oxford BRC on the patient
care provided at the OUH hospitals, we used a multi-phase
approach. First, we reviewed documentation provided by
the Oxford BRC (including its own reports and other docu-
mentation concerning its research) and relevant literature
on evaluating the impact of research activity on patient
care. This work was conducted to inform our approach in
the subsequent phase of this study, rather than to provide
an analysis of all the existing literature in this area.
Second, we spoke to representatives of the Oxford
BRC (leaders of the 14 RTs and 3 of the WGs). The pur-
pose of these interviews was to identify the impacts that
the RT and WG leaders in Oxford BRC expected would
have resulted from their RT/WG work, including both
direct and indirect impacts. This information was used
to provide background and structure to a subsequent set
of interviews with senior OUH clinicians.
Third, we interviewed senior OUH clinicians responsible
for patient care (the Directors of the hospital’s clinical Divi-
sions and Directorates) to find out what impacts they had
observed and to test whether the impacts that the Oxford
BRC RT/WG leads expected were observed by the clini-
cians. We targeted our interviews at this level of seniority,
within the constraints of budget and timescale, in order to
cover all areas of patient care. It is possible that different
impacts of research activity might be felt, and to different
degrees, at different levels. The OUH clinicians were asked
first about the effects of research activity generally in their
Division or Directorate, and were then asked about Oxford
BRC research specifically. We then identified a set of
themes from the responses to these interviews.
Fourth, we conducted a ‘cross analysis’ in which we
compared and contrasted the results from the two sets
of interviews.
Finally, we compared the themes which had been
identified from the senior clinician interviews with the
mechanisms outlined by Hanney et al. [10] (Box 1). The
purpose of this was to test the list of suggested mecha-
nisms against our results and not to force our results
into the categories suggested by Hanney et al.
Box 1 Mechanisms through which healthcare improved in
research-active settings (adapted from Hanney et al. [10])
1. Absorptive capacity (most relevant for wider adoption of research in
institutions):
• Changes in the structure of institutions – improvements in
infrastructure:
○ Attributes of the setting in which care is delivered, such as
accommodation, equipment and personnel, which are brought in
to perform research-related activities and may remain in place after
the research is completed
• Changes in human capital:
○ Training/updating staff through research engagement leading to
the acquisition and use of new skills, other gains in knowledge and
changes in attitudes towards research and research findings
○ Enhancement of group and individual behaviour including more
rapid uptake of new treatments, greater likelihood of following
clinical guidelines
2. Improvements in the processes of care related to conducting a
specific trial:
• A more rigorous process of defining the standard of care for
patients irrespective of their inclusion in the trial
• Closer monitoring and support
• Early access to novel technologies
3. Organisational mechanisms within healthcare systems:
• Example: In the American Veterans Administration system, the whole
organisation uses research to improve healthcare. Improvements can
occur through conducting research to address known issues in the
healthcare system, allowing physicians time to conduct research and
thus being an attractive organisation to work for, conducting research
to identify best performance targets to set, using research in quality
improvement, etc.
4. Collaborative approaches between organisations, teams and individuals:
• Interactions that improve the relevance of research and the
willingness of policymakers/managers/clinicians to use it
• Research networks as an increasingly important mechanism
5. Action and participatory research as mechanisms that improve
relevance, understanding of and willingness to use research
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Oxford BRC Research Theme/Working Group (RT/WG)
lead interviews
The Oxford BRC’s RT/WG leads were informed about
the study and purpose of the proposed interviews by
email and in person (by JS) at one of their monthly
meetings. They were then invited by email to participate
in the interviews. Invitations were sent to all 14 of the
Oxford BRC RT leads plus 3 WG leads. The latter were
interviewed at the recommendation of the Oxford BRC
manager on the basis that their WG work may also have
brought about observable impacts in the OUH. All 17 of
the invited RT/WGs, listed in Box 2, provided a repre-
sentative to participate in the interviews.
The interview protocol (Additional file 1) was sent to
the interviewees 2–3 days in advance of the interview.
The protocol included a reminder of the project goals
and activities, a note on confidentiality, and the ques-
tions which would be used to guide the discussion.
Seventeen interviews were conducted, by telephone, by
one researcher in each case (CL, GM or JS), from Septem-
ber to November 2015. The interviews each lasted 45–60
minutes and were audio recorded with consent of the inter-
viewees. After each interview, the notes were shared with
the interviewees and their co- and/or deputy-leads to allow
for amendments or corrections. The notes were detailed
and covered the majority of the conversation, but were not
full transcripts. For the majority of the interviews, there
was one interviewee present, namely the RT lead or WG
lead or one of the co-leads. In two cases, the interviewee
was a colleague nominated by the lead; in four cases, the
interviewee was joined by a colleague from the RT/WG.
The interviews were semi-structured so as to elicit compar-
able answers across the RT/WGs to common questions,
while also encouraging open responses discussing the types
of impacts and the pathways by which they are achieved.
The questions were designed to explore the expected
direct and indirect impacts of specific research projects
that have been part of each theme, with the focus primar-
ily on impacts felt at OUH. The section on indirect effects
specifically highlighted collaboration and interaction,
absorptive capacity, infrastructure and human capital,
action and participatory research, and economic impacts
(note that economic impacts are not the focus of this
paper; responses to these questions were used to inform a
parallel research project to be reported separately).
Interviews were analysed systematically. First, the
researcher who had conducted the interview entered the
results concisely into an Excel spreadsheet, so that the
outcomes of all 17 interviews could be seen together.
The results were grouped into ‘key areas’ with a distinc-
tion made between direct and indirect impacts. Where
relevant, we aligned the ‘key areas’ with the categories of
mechanisms listed by Hanney et al. [10], but we did not
force the responses into the categories where they are
not a good fit. All researchers who had conducted the
RT/WG interviews (CL, GM and JS) reviewed the
overall spreadsheet and identified where clarification
was needed, which the relevant interviewer then
actioned. In total, across the 17 interviews, 44 projects
or clinical services enabled by Oxford BRC-related
projects were identified by RT/WG leads as expected
to have a direct impact on the OUH. They are listed
Table 1 in the results section. The study team identified,
for each item on the list, which clinical areas within the
OUH might be expected to have encountered it.
OUH senior clinician interviews
The OUH is organised into five Divisions, with two to
five Clinical Directorates per Division, giving a total of
18 Clinical Directorates. All 23 of the divisional directors
and clinical directors were invited to participate in the
interviews and all 23 were clinicians. They were in-
formed about the study and the purpose of the inter-
views via an email from the office of the Oxford BRC
Director, who was also the OUH Director of Research.
The email explained that the study had been commis-
sioned by Oxford BRC to understand the extent of its
impact and to explore how it could operate more effect-
ively in the future.
Nineteen of the 23 clinical heads of Divisions/Director-
ates participated in the interviews, as did three of the five
divisional heads and 16 of the 18 heads of the Directorates
Box 2 Oxford BRC research themes and working groups whose
leads were invited to be interviewed
Research Themes
1. Biomedical Informatics and Technology
2. Blood
3. Cancer
4. Cardiovascular
5. Dementia and Cerebrovascular Disease
6. Diabetes
7. Functional Neuroscience and Imaging
8. Genomic Medicine
9. Immunity and Inflammation
10. Infection
11. Prevention and Population Care
12. Surgical Innovation and Evaluation
13. Translational Physiology
14. Vaccines
Working Groups
15. Clinical Informatics
16. Molecular Diagnostics
17. Training and Education
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Table 1 Summary of Oxford Biomedical Research Centre (BRC) projects that Research theme/Working group leads indicated had
potential impacts on patient care at Oxford University Hospitals NHS Foundation Trust (OUH)
BRC Research theme/Working group Oxford BRC projects with potential impact on patient care Potential impact on patient care at
OUH
Biomedical Informatics and Technology Gestational diabetes smartphone application Processes and/or service organisation
New alerting score based on patients’ vital signs
(CALMS-3 Study – Computer Alerting Monitoring System)
Processes and/or service organisation
Maintenance of database of samples and consent management
for Oxford Biobank
Processes and/or service organisation
System for Electronic Notes Documentation (SEND)
project (electronic track and trigger and patient alerting)
Processes and/or service organisation
Blood Training and hiring staff and improving infrastructure for clinical programme
to do stem cell transplants and run more clinical trials in this area
Treatments
Cancer Multi-gene testing service with rapid (1 week) turnaround Diagnostics, testing, screening
BRC-funded clinical research posts specialising in sarcoma,
gynaecological cancers and melanoma
Staffing for specialist services
Cardiovascular MRI diagnostic tools for patients with intermittent angina Diagnostics, testing, screening
Clinical Informatics Upgrade for cancer informatics in OUH (enabled by Genomic
Medicine Centre (GMC) designation)
Diagnostics, testing, screening
Molecular diagnostics and genome sequencing services
(enabled by GMC designation)
Diagnostics, testing, screening
Development of integrated logical record for each cancer patient (in progress) Processes and/or service organisation
True colours technology for mental health patients across Oxfordshire to aid
self-management
Processes and/or service organisation
Streamlining management of notes/records from multidisciplinary cancer
meetings (in progress)
Processes and/or service organisation
Clinical decision support dialogue to make blood orders more efficient Processes and/or service organisation
Dementia and Cerebrovascular Disease New screening process for acute confusion in medical admissions Diagnostics, testing, screening
Fast track carotid surgery Treatments
Telemetric home blood pressure monitoring Processes and/or service organisation
The first transient ischaemic attack (TIA) and minor stroke
clinic in the United Kingdom
Processes and/or service organisation
Diabetes Diagnostic programme to identify patients with a genetic basis
for their diabetes
Diagnostics, testing, screening
Pancreatic islet extraction unit Treatments
Pancreatic transplants Treatments
Functional Neuroscience and Imaging Imaging protocols (epilepsy) Diagnostics, testing, screening
Functional neurosurgery team (part of the BRC) provides a
clinical service, including pain deep brain stimulation
Treatments
Specialist clinic in epilepsy, Parkinson’s disease, motor neurone
disease, supported by BRC-funded research fellows
Staffing for specialist services
Genomic Medicine Targeted next generation sequencing Diagnostics, testing, screening
Whole exome or whole genome sequencing Diagnostics, testing, screening
Immunology and Inflammation Non-invasive tests for liver disease Diagnostics, testing, screening
Patient stratification for biologic therapies Diagnostics, testing, screening
Tests to diagnose encephalitis (brain inflammation) Diagnostics, testing, screening
Trials on treatment of inflammation in eczema Treatments
Infection Work linking care to outcomes with big data approaches Processes and/or service organisation
Genomic testing to support infection monitoring (provided informally) Processes and/or service organisation
Molecular Diagnostics Oxford designated as GMC for Genomics England’s 100,000 Genomes Project Diagnostics, testing, screening
Multi-gene testing for cancer patients Diagnostics, testing, screening
Diagnostic tests for children with rare blood conditions Diagnostics, testing, screening
Response prediction in leukaemia Diagnostics, testing, screening
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which fall within those Divisions. Four declined to be inter-
viewed (two divisional directors and two clinical directors;
Box 3). One interviewee changed roles from clinical dir-
ector to divisional director during the course of the study.
Two of the divisional directors were also Oxford BRC
RT leads; they were interviewed again for this phase of the
study, and asked to discuss their observations from the
perspective of their roles as divisional directors. These
interviewees’ status as RT/divisional director hybrids is
likely to have impacted their responses (i.e. the responses
are based not only on their experiences as divisional direc-
tors but naturally influenced by the research that they are
involved in) and we have therefore identified this within
the results section where it may affect the findings.
The interviewees were sent a reminder by email 2 or 3
days ahead of the interview. The email reiterated the
purpose of the interview, noted that interviewees were not
expected to prepare for the interview or be familiar with
the Oxford BRC, and included the list of indirect impacts
that would be asked about (Box 1). The list was sent to fa-
miliarise interviewees with the notion of indirect impacts,
so that they did not unnecessarily limit their thinking
solely to direct impacts. (The interviews were to deter-
mine whether and how Oxford BRC research projects
were considered by clinicians to be impacting patient care
at their hospital, not to test clinicians’ familiarity with the
Hanney framework). No mention was made of any
individual Oxford BRC research projects at this stage.
All of the clinician interviews were carried out face-to-
face at the OUH hospitals in Oxford (the interviewers
were AP, CL, GM and JS) in December 2015 and January
2016. At each interview, one researcher conducted the
interview and another took notes. The notes were based
on concurrent note-taking (rather than audio taping)
and were detailed but were not full transcripts. The
notes were shared with the interviewees shortly after the
interview to allow for corrections or amendments. For
the majority of the interviews, only the invited inter-
viewee was present; for two interviews, a colleague of
the interviewee joined and contributed.
The interviews followed a structured protocol
(Additional file 2) to ensure comparability of responses
Table 1 Summary of Oxford Biomedical Research Centre (BRC) projects that Research theme/Working group leads indicated had
potential impacts on patient care at Oxford University Hospitals NHS Foundation Trust (OUH) (Continued)
Prevention and Population Care The first TIA and minor stroke clinic in the United Kingdom Processes and/or service organisation
Surgical Innovation and Evaluation Chemotherapy (device targeted therapy): liposomes
developed to carry the treatment to the organ of interest
Treatments
Image-guided surgery using fluorescents Treatments
Organ transplantation/reconditioning Treatments
Restoring vision through an electronic implant Treatments
Restoring vision through gene therapy Treatments
Training and Education No projects identified
Translational Physiology No projects identified
Vaccines Respiratory syncytial virus, trialling a new vaccine Treatments (national)
Meningitis, looking at trials of schedules for baby vaccines,
booster doses, meningitis B vaccine trials
Processes and/or service organisation
(national)
Multiple research themes/Working groups Better infrastructure for clinical trials and other studies
(e.g. better pharmacovigilance, biobanking)
Processes and/or service organisation
Box 3 Divisions and constituent Clinical Directorates at OUH
Neurosciences, Orthopaedics, Trauma and Specialist Surgery Divisiona
Neurosciences Directorate
Orthopaedics Directorate
Trauma Directoratea
Specialist Surgery
Children’s and Women’s Division
Children’s Directorate
Women’s Directorate
Medicine, Rehabilitation and Cardiac Divisiona
Acute Medicine and Rehabilitation Directorate
Ambulatory Medicine Directorate
Cardiology, Cardiac and Thoracic Surgery Directorate
Surgery and Oncology Division
Oncology and Haematology Directorate
Surgery Directoratea
Renal, Transplant and Urology Directorate
Churchill Theatres, Endoscopy and Gastroenterology Directorate
Clinical Support Services Division
Theatres, Anaesthetics and Sterile Services Directorate
Adult Critical Care, Pre-operative Assessment, Pain and Resuscitation Directorate
Pathology and Laboratories Directorate
Radiology and Imaging Directorate
Pharmacy Directorate
aDirector declined interview
Divisions are shown in italic font; Clinical Directorates in normal font
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across interviews. At the start of each interview, the
interviewee was reminded about the purpose of the inter-
view. The questions about the impact of research activity
were divided into three parts:
Part 1
Observations about research as it relates to the Director-
ate’s/Division’s clinical work. These questions explored
the role of research in the Directorate/Division and
OUH staff involvement with research. It included a
series of 10 questions covering the types of indirect
impacts outlined in the Hanney Framework (Box 1).
Part 2
Observations about Oxford BRC-specific research activ-
ities. These questions focused on the impacts of Oxford
BRC research specifically and the role of the Oxford
BRC.
Part 3
Specific examples of Oxford BRC projects. Interviewees
were first asked, without prompting, to name any
Oxford BRC projects they were aware of and that had
affected patient care in their Directorate/Division. Once
no further projects were forthcoming, each interviewee
was then prompted with a set of projects. These were
items (usually 4–5) from the list of 44 examples of direct
impacts given by the Oxford BRC RT/WG leads that the
researchers considered the interviewee may be familiar
with because they had a potential impact on the work of
that Directorate/Division.
The interviewees’ responses were systematically coded
and analysed. First, one researcher who had participated
in the interview (AP, CL, GM or JS) entered relevant
comments from each interview into a spreadsheet matrix
(rows = interviewees, columns = interview questions).
These entries were then reviewed by the second re-
searcher present for each interview (AP, CL or GM) and
any differences of interpretation were discussed and
resolved. Then, for each question in turn, a researcher (CL
or GM) compared the responses across the 19 interviews,
assessing the different types of response and quantifying
how many respondents gave each type of response. These
summaries were then checked by another researcher (JS).
Finally, the whole research team discussed the results and
emerging themes across questions, and agreed the final
list of themes.
Cross-analysis of results
To obtain a more complete picture of each of the
themes identified from the analysis of the OUH clinician
interviews data, we reviewed comments made by RT/
WG interviewees that aligned with the themes we identi-
fied from the clinician interviews. We compared and
contrasted the perspectives of the two sets of inter-
viewees and summarise this analysis in the final results
section (note that the RT/WG interviewees were not
systematically asked about the themes that arose in the
interviews with clinicians, which took place after the
RT/WG interviews).
Results
Results of the RT/WG leader interviews
Based on what they told us, we have grouped the RT/WG
leads’ responses to the interview questions into the
following main areas (note that some of them, but not all,
correspond to mechanisms suggested by Hanney et al.
[10] (Box 1):
 Direct impacts of Oxford BRC research on patient
care
 Indirect impacts:
○ Absorptive capacity: infrastructure
○ Absorptive capacity: developing human capital
○ Improvements related to clinical trials
(enabling more trials or closer monitoring and
support)
○ Collaborative working and participatory
research
We report here our findings from what was said in the
interviews. They should not be taken to represent a
comprehensive account of all BRC projects (as there are
over 400 of them) or all possible impacts of those
projects.
Direct impacts
Interviewees explained that more than half of the
Oxford BRC budget is used to pay staff salaries, while
the rest covers the costs of consumables and other
research-related activities. The direct impacts de-
scribed were thus related to projects carried out by
staff who were at least partly Oxford BRC-funded, or
were related to other activities or improvements in
research capacity that were enabled by the Oxford
BRC’s support.
The RT/WG interviewees identified 44 projects or
clinical services enabled by Oxford BRC-related projects
that they thought had directly impacted the care of
OUH patients and/or the organisation of clinical services
in the OUH. These Oxford BRC projects are listed in
Table 1. To better understand the types of impacts
occurring, we have grouped the projects according to
four areas of primary impact, with each project falling
within just one of the four headings:
 Diagnostics, testing or patient screening
 Treatments available
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 Processes for delivering patient care and/or
organising hospital services
 Staffing for specialist services
Among the total of 44 projects, 16 had impacts related
to diagnostics, testing or patient screening, 12 on treat-
ments available, 14 were related to processes for delivering
patient care and/or organising hospital services, and two
had impacts on staffing for specialist services (Table 1).
Many of the RT/WG interviewees also described ongoing
projects they thought were likely to have future impacts
on OUH; however, the present study focuses on existing
impacts, so these are not listed.
An example of a development that affected the diagno-
sis or screening of patients is that Oxford was designated
as one of the 11 NHS Genomic Medicine Centres
(GMCs) in 2014. One interviewee explained that the
Oxford BRC had played an important role in enabling
Oxford to achieve this designation, and that it had led to
a major upgrade for cancer informatics services as well
as boosting OUH’s molecular diagnostic and genome
sequencing services. Another interviewee had observed
that genetic testing services had improved, with the
turnaround time for results shortened.
A project that impacted how care is organised and
delivered was the System for Electronic Notes Docu-
mentation (SEND) project, an electronic system for pa-
tient monitoring and staff alerting that was developed
with Oxford BRC support and was being rolled out
across OUH’s four hospitals at the time of the interview.
The Oxford BRC was also seen to have impacted on
specialist clinics in epilepsy, Parkinson’s disease and
motor neurone disease, which are supported by Oxford
BRC-funded research fellows.
Indirect impacts
Absorptive capacity: infrastructure
Interviewees reported that Oxford BRC provides re-
search infrastructure support to the OUH in two ways
and thereby has a positive impact on patient care: it
enables more clinical trials and other research studies to
be carried out (discussed in a separate section below),
and it contributes indirectly to the acquisition of equip-
ment used for research. One interviewee reported that
the presence of staff from the Oxford BRC’s WGs on
Clinical Informatics and Molecular Diagnostics had en-
abled OUH to demonstrate that they had the necessary
capabilities to become a Genomic Medicine Centre,
which in turn enables better care at OUH.
Other forms of Oxford BRC-related improvements to
infrastructure at OUH that were cited were better
biobanking, including a tissues database and consent
management system (cited by three interviewees) and
improved pharmacovigilance and pharmacy support
(cited by two interviewees). Overall, the idea that the
Oxford BRC is an important enabler came across
strongly in the interviews with RT/WG leads. As one
RT lead said: “The BRC is highly enabling to [our
work in applying state of the art techniques to answer
pressing problems] because it gives us resources, it
gives us focus”.
Eight RT/WG interviewees explained that, whilst
BRC funding by NIHR is not provided for capital
spending, the Oxford BRC helps contribute to legit-
imate revenue costs and RT leads are asked to source
capital expenditure from other funding sources. For
example, in the Genomic Medicine RT, all of the se-
quencing technology platforms were purchased with
funds from research grants. In this case, the equip-
ment subsequently became available for non-research
use by OUH staff. Another interviewee suggested that
the Oxford BRC may have helped the Oxford Centre
for Functional MRI of the Brain, a neuroimaging re-
search facility, to attract some of its funding.
Interviewees reported that the Oxford BRC also con-
tributes to the running costs of some facilities at OUH,
with the following examples each being mentioned once:
the Acute Vascular Imaging Centre (AVIC), an advanced
clinical research facility that has an MRI scanner con-
joined to an angiography suite; the Oxford Centre for
Diabetes Endocrinology and Metabolism (OCDEM)
pancreatic islet extraction unit; and the Oxford Clinical
Biomanufacturing facility, which produces products for
early-phase clinical trials. The Oxford BRC has also
provided funding for consumables and smaller scale
equipment such as blood pressure monitors. Through
one RT, the Oxford BRC covered the cost for patients to
receive genetic tests that assess whether there is a
genetic basis for their diabetes. In another RT, the
Oxford BRC funded scans that were part of a larger
project on acute myocardial infarction. Interviewees
said it would be difficult to purchase these services,
pieces of equipment and consumables without Oxford
BRC funding.
Absorptive capacity: developing human capital
The main mechanism through which the Oxford BRC
supports human capital development at OUH is funding
for staff to do research. This includes paying for medical
staff to reduce their clinical hours and devote some time
to research, funding research fellows and trainees who
also do clinical work, and paying for non-medical staff
such as nurses to do, and contribute to, research. Six
interviewees referred to the importance of Oxford BRC-
funded research nurses for doing clinical research,
although one interviewee also noted as a downside that
nurses who move into wholly research positions do not
usually go back to working on the wards, which can
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imply a loss of high quality staff from patient care. Also
mentioned was Oxford BRC support for radiographers,
genetic counsellors, statisticians, pharmacists, project
managers with expertise in clinical governance, and
database staff. Five interviewees mentioned that it would
not have been possible to engage these staff without the
Oxford BRC.
The opportunities to have time ‘bought out’ or ‘pro-
tected’ for research and the increased involvement of
clinical staff in research were seen by several RT/WG in-
terviewees as having had positive effects on recruitment
and organisational culture at OUH. Six RT/WG inter-
viewees expressed the view that the research opportun-
ities offered by the Oxford BRC help attract and retain
high-quality staff, and one added that the Oxford BRC’s
reputation also attracts staff (both medical and non-
medical). One interviewee explained that the Oxford
BRC has “provided more headroom” for busy staff to
think about and do research by introducing additional
funding and increasing time available for research and
implementation of new programmes. Another said that
the Oxford BRC had “transformed” research in intensive
care by helping to bring in more researchers, including a
clinical lecturer, clinical academic fellows and academic
foundation doctors.
Some of the interviewees felt that, by allowing more
staff to do research, the Oxford BRC is helping bring
about a cultural change through which research is
gaining traction and becoming more important in the
day to day work of the OUH. They described a posi-
tive feedback loop, where OUH employees’ increased
involvement in research leads to more research inter-
actions, and a change in attitudes toward research. Some
reported that research became more deeply embedded
within the clinical departments. However, this view was
not shared by all of the RT/WG interviewees; one
explicitly said that no cultural change had occurred and
that “research is still seen as being for researchers, not
everyone”.
In addition to the Oxford BRC’s role in supporting the
staff who do research (including research fellows, con-
sultants and non-medical staff ), interviewees described
how the Oxford BRC helps to develop human capital by
enabling medical trainees to obtain research experience
and formal research training. Representatives of the
Research Education and Training WG cited Oxford BRC
funding for doctorates, clinical fellowship schemes,
training bursaries and other courses.
Five interviewees highlighted examples of training tak-
ing place within their RTs. This included opportunities
for junior doctors to receive research training as well as
opportunities for staff to learn new techniques, access
new technologies, and be “exposed to different ways of
thinking about disease”. One interviewee emphasised
that junior doctors are encouraged to attend weekly re-
search meetings and get involved in research, so that
they could become “research-trained doctors, not ordin-
ary doctors”. This interviewee commented that, without
being able to have some of their time protected for re-
search, NHS trainees cannot step off their training
pathway and obtain research experience. Another inter-
viewee reported that a cohort of haematologists and
PhD fellows in haematology had been trained with sup-
port from the Oxford BRC and other funding sources.
Some formal training opportunities target non-medical
staff. For instance, an interviewee reported that within
their RT, nursing staff have been on Oxford BRC-funded
training courses related to treatment of stroke and
hypertension patients. Other interviewees explained that
an orientation pack has been developed with Oxford
BRC funding for people entering new jobs as research
nurses, and that other Oxford BRC-funded training op-
portunities have included courses on how to prepare pa-
tients for trials, laboratory skills, research methodology,
design and statistics, and management.
Improvements related to clinical trials
One interviewee explained that the Oxford BRC sup-
ports senior staff who have critical knowledge of how to
set up clinical trials and how to write protocols, con-
tracts and ethics submissions. Four RT/WG interviewees
described how the Oxford BRC had helped to increase
clinical trials capacity and enabled more trials to take
place. For example, one interviewee explained that, in
their field, clinical research had previously been under-
taken on a relatively small scale and had grown with the
Oxford BRC so that now approximately 2000 patients
are recruited for studies each year. Another interviewee
said that they used to run just two or three clinical trials
at a time but now they run more than 60, and that the
change was enabled in part by the establishment of a
clinical trials unit run by staff who receive funding from
a mix of sources including the Oxford BRC. Two inter-
viewees felt that the Oxford BRC had a particular impact
on improving the quality and scope of early-phase trials
done in the OUH.
Collaborative working and participatory research
A commonly stated view across the RT/WG leads was
that the Oxford BRC had led to more active collabor-
ation between OUH clinical staff and academic re-
searchers. One interviewee described this collaboration
as an important part of the ‘ethos’ of their RT, while an-
other observed that Oxford BRC funding is dependent
on collaboration and had thus brought about a different
way of working. Others commented that the Oxford
BRC enables collaboration because more staff hold joint
appointments with both the University of Oxford and
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the OUH. Two interviewees explicitly stated that the
introduction of these joint appointments together with
the Oxford BRC’s research nurses had “bridged the gap”
between the University and the OUH.
In addition, two interviewees reported that the Oxford
BRC has worked hard to align its research with the
OUH’s strategic priorities. Two interviewees explained
that both the University and the OUH benefit from the
increased collaboration, as the academics gain the op-
portunity to collaborate with clinical personnel and work
with patients, while the NHS gains access to research
funding and research capabilities. They emphasised that
the interaction helps leverage more research funding
(including grants and industry collaborations) into both
the OUH and the University.
RT/WG interviewees also described how increased
participation by hospital staff had made research more
clinically relevant and raised the profile of research in the
OUH. Three interviewees explained that research rele-
vance was increased as researchers were brought closer to
the clinical setting and would thus ask more clinically
relevant questions, with one saying that researchers with a
“clinical footprint” are more likely to undertake research
that is clinically relevant. Another interviewee explained
that the Oxford BRC seeks to do translatable, economic-
ally viable research, and so Oxford BRC researchers are
expected to deliver projects in line with these aims. One
interviewee described how the SEND project had evolved
through collaboration between bioengineers and full-time
clinicians. They predicted that as SEND was rolled out,
clinicians who use it would be interested in getting more
actively involved with it – both by providing suggestions
to further develop it and by making use of the data it
collects. Interviewees also noted that research that has
been demonstrated to work in a clinical setting has more
credibility, and that staff become more interested in
research after seeing its tangible benefits. One interviewee
added that they felt the Oxford BRC had dramatically
improved the perception of research within the OUH: “It
is undoubtedly the case that the profile of what we do,
particularly among non-medical NHS staff, has been
greatly enhanced by the BRC”. However, the same inter-
viewee acknowledged there is still some way to go in making
the link between research and clinical application seamless.
Six interviewees felt that the Oxford BRC has in-
creased the profile of patient engagement in research or
identified positive achievements of the Oxford BRC’s
patient and public involvement (PPI) work. However, the
remaining respondents were either unsure whether there
had been an impact in this area or did not discuss
Oxford BRC-related PPI activities. Of those who did
consider that there had been an impact, one highlighted
that training is run with the Oxford BRC’s PPI WG to
raise awareness among the researchers; and three
highlighted that the Oxford BRC has held popular Open
Days to showcase its work to patients and public. Inter-
viewees described examples of how the Oxford BRC’s
PPI work programme is having a visible impact. Two
described examples of how patients had been signifi-
cantly involved in research design; two others mentioned
that researchers are asked to write lay summaries of
their work with help from the PPI working group; and
another noted that an Oxford BRC research nurse sits
on the hospital’s patient forum.
Results of the OUH senior clinician interviews
The interviews with the RT/WG leads, supported by our
review of Oxford BRC documents, provided an overview
of the RT/WG leads’ research activity and where they
would expect OUH staff may have felt an impact from
that research. It is to be expected that the RT/WG leads
would tend to a positive view of the impact of the Ox-
ford BRC on healthcare in OUH although limitations to
that impact were also recognised. While the purpose of
the interviews with the RT/WG leads was to determine
the potential scope of impacts, the purpose of the inter-
views with senior clinicians responsible for patient care
at OUH was to determine to what extent such impacts
were observed in practice. In the interviews with clinical
heads of Directorates and Divisions at OUH, we first dis-
cussed the impact of research activity at OUH on patient
care. We then asked more specifically about the contri-
bution of the Oxford BRC to that impact. When arran-
ging the interviews with OUH senior clinicians, the
request for interviews explicitly stated that the study had
been commissioned by Oxford BRC. At the interviews
themselves, all 19 interviewees (100%) confirmed that
they were aware of the Oxford BRC. More informatively,
nine (47%) of them went further to say that they were fa-
miliar with, or work directly with, the Oxford BRC.
The results from these interviews are discussed in the
following pages in four parts: first, we outline the themes
which were identified from the interviewees’ responses;
second, we provide a summary of interviewees’ aware-
ness of specific Oxford BRC-related projects; third, we
discuss the impact of the Oxford BRC on collaboration
between OUH staff and others, including University
researchers; and finally, we analyse the responses in the
context of the Hanney framework.
Themes from the interviews with OUH clinicians
Our thematic analysis of the full set of interview notes
led us to identify 10 themes emerging from the discus-
sions with senior clinicians at OUH:
1. Research activity
2. Formalisation of research roles
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3. Communication and awareness of research
4. Reputation
5. Staff recruitment and retention
6. Patient benefits from staff involvement in research
7. Access to infrastructure
8. Novel treatments and technologies
9. Attitudes to research
10.Collaboration
Note that many of these themes link together and
overlap with each other. For example, it is likely that
reputation (Theme 4) aids staff recruitment and reten-
tion (Theme 5), and that attitudes to research (Theme 9)
are influenced by communication and awareness
(Theme 3). The themes that emerged from the inter-
views with OUH senior clinicians correspond to varying
degrees with the mechanisms in the Hanney framework.
Each theme is discussed in turn below, including how it
relates to the Hanney framework. Then, the combined
picture across all themes is summarised. The majority of
the themes point to some positive changes that have been
achieved, but some also highlight negative consequences.
Theme 1 – Research activity Fifteen of the 19 inter-
viewees (79%) stated that research does affect the NHS
work (i.e. patient care) done within their Division or Dir-
ectorate of the OUH, either positively or negatively or
both. One of these respondents elaborated that: “all
patients are considered research patients by default”. An
additional three interviewees (16%) gave mixed re-
sponses, indicating that, whilst research is undertaken, it
is not clear whether, or how far, this influences clinical
work. Three respondents added that the amount that
research affects the NHS work done varies depending on
the clinical area. Only one interviewee (5%) said that
research had no effect on patient care within their
Directorate, which was a clinical support service. Taking
all of these responses together indicates overall that there
is the potential for substantial impact from research activ-
ity on OUH’s patient care services. The extent to which
this impact was described as beneficial or otherwise is set
out in the following sections, covering the other nine
themes that emerged from the interviews with clinicians.
Interviewees were also asked to what extent clinical
staff are involved in research and their responses indi-
cate that this varies significantly. Seven interviewees
(37%) indicated that they have many research-active col-
leagues, and a further five interviewees (26%) (one of
whom was one of the divisional directors who is also an
RT lead) indicated that all staff contribute to research as
part of their regular work, e.g. CT scans or supplying
medicines from the hospital pharmacy. Five respondents
(26%) indicated that a minority have funding for re-
search time, and four (21%) noted that there is higher
involvement in research amongst consultants and other
medical staff, compared to non-medical staff. Seven respon-
dents (37%) noted that the involvement of clinical staff
within research varies a lot between different staff members
and between different units within the Directorates.
When asked whether clinical staff involvement in re-
search had changed over time, 11 of the 19 interviewees
(58%, including the two divisional directors who were
also RT leads) felt that it had increased over time, one
(5%) felt that it had decreased, and two (11%) felt that
there had been no change. The remaining five responses
(26%) offered no clear view.
Interviewees were aware of many Oxford BRC pro-
jects, and gave the impression that overall research ac-
tivity continued to increase at OUH, at least in part due
to the Oxford BRC. Thinking specifically about the Ox-
ford BRC, 17 of the 19 OUH interviewees (89%) noted
that the presence of the Oxford BRC has affected the re-
search activities happening in their Directorate or Div-
ision. Of the two who said it has not, one works more
closely with the separate NIHR Biomedical Research
Unit based at the Nuffield Orthopaedic Centre (one of
the four hospital sites within the OUH) than with the
Oxford BRC, and the other suggested that research has
no or little effect within their Division.
It is clear that Oxford BRC research plays a substantial
role within the totality of research activity at OUH, but
that involvement varies quite widely between Director-
ates/Divisions and interviewees were not always aware
of what research was linked to the BRC. Eight inter-
viewees (42%, including both of the divisional directors
who were also RT leads) indicated that the proportion of
research taking place within their Directorate or Division
that is linked to the Oxford BRC in some way was large
or a majority. An additional four (21%) indicated that
the proportion was around 20–30%. Of the remaining
seven, six (32%) felt unable to estimate the proportion,
and one reported that no Oxford BRC research took
place (this was the same respondent who indicated that
research has no effect within their Division).
Interviewees were asked to consider the effects of the
Oxford BRC hypothetically doubling in scale. The major-
ity (14 respondents (74%), including the two divisional
directors who were also RT leads) felt that this could be
a positive change, but seven of these felt that such a
change would need to be handled carefully because of
the impacts research could have on staffing and physical
space, for example. Specifically, two interviewees stated
that the current allocation of funding is not spread
evenly across the board; some areas already have a lot of
research and may be saturated. Three interviewees noted
that, in the words of one of them, “any increase in fund-
ing would be less effective if it was put into areas which
already have a lot of research underway”.
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When asked the opposite question, i.e. what would be
the impact if hypothetically all of Oxford BRC’s funding
were to be removed, only one respondent thought it
would make no difference to their area of clinical work.
All other respondents said the impact would be negative,
but their answers ranged from describing small scale
impacts to it being a “disaster”. One interviewee said:
“There would be a huge vacuum in activity because of
how the BRC gets into the space between lab research
and clinical work”. Another commented that “there
would be a need to cut some clinical activities because
the BRC funding sometimes supports activities that are
clinical but for research purposes”.
Theme 2 – Formalisation of research roles Inter-
viewees explained that increases in research activity have
led to increases in research staff numbers. They said that
involvement in research is now usually formalised with a
clear distinction between individuals and, for each
individual, between the different periods in the working
week that are for research rather than patient care.
Greater formalisation has the advantage, mentioned by
several of the clinicians, of enabling research to be part
of programmed activities rather than being squeezed
into clinicians’ ‘spare time’. This was seen as allowing
more ‘head space’ to think about research, with Oxford
BRC and other research funding enabling staff to be
recruited to cover for the time when clinicians work on
research rather than provide patient care. The Hanney
framework refers to this same set of issues as part of the
third type of mechanism, as it lists ‘organisational
mechanisms within healthcare systems’.
Thirteen of the 19 interviewees (68%) stated that re-
search had changed how personnel are organised, three
(16%) each said there had been no such change or were
unsure or their answer was unclear. One interviewee
mentioned that there are “lots more research nurses”
around, and three others that clinical staff have given up
sessions to do research. While this may facilitate more
and better research, its impact on patient care is less
clear. This latter point was echoed by three interviewees
who described how clinical staff can be tempted away
from a stressful clinical environment into less stressful
research posts and how research can create a tension
where some of the best staff are recruited to research
posts full time and thereby taken away from patient care.
This can be the case for nurses as well as medical staff.
When asked about factors that encourage staff to be
involved in research, 6 of the 19 interviewees (32%) men-
tioned the opportunity to have protected time for research
(either by the Oxford BRC or another source) as a key
factor. In addition, when asked about barriers to research,
14 of the 19 (74%) mentioned a lack of time for research
due to clinical workload as a key issue. This highlights that
there is not always time or opportunity for someone to be
involved in research, unless (some of) their time is for-
mally allotted to research. When asked whether these en-
ablers and barriers had changed over time, two
interviewees specifically noted that now the only people
doing research are those who are employed to do that,
whereas in the past others had time for it too.
Some staff undertake both research and patient care
activity. One interviewee commented that, whilst in-
creases in staff are generally for research purposes, a key
exception are clinical academics who are employed by
the University. These clinical academics spend approxi-
mately half of their time working for OUH. In addition,
some staff hold split posts (partly research, partly
clinical), or have some of their clinical time ‘bought out’
(and therefore protected) for research. These split
contracts have increased with the advent of the Oxford
BRC. Another interviewee provided the example of some
research fellows, who may be doing full time research,
also contributing to on-call rotas at night, thereby redu-
cing the burden of the night rota for clinical staff.
Theme 3 – Communication and awareness of re-
search This theme relates to internal and external com-
munication about and awareness of current research
activities, and the resulting effects on staff and patients.
Hanney et al. [10] found from the literature that improv-
ing the absorptive capacity of staff who provide patient
care is associated with improved quality of care. It is part
of the first mechanism on their list by which research-
active settings improve patient care. Communication
and awareness of research contribute to that absorptive
capacity.
When asked about factors that encourage staff involve-
ment in research, four OUH senior clinician inter-
viewees (21%) mentioned exposure to research, and two
further interviewees (11%) mentioned awareness and
opportunities. Four interviewees (21%) also stated that
there have been improvements in raising awareness and
providing more opportunities for research participation
over time, one of whom stated that more of this is
needed. Examples mentioned of ongoing activities to
increase communication and awareness included semi-
nars and discussions to disseminate research, and a
board to display research posters from conferences.
The interviewees were also asked whether ongoing
research has raised the profile of research within their
Directorate or Division. Twelve of the 19 interviewees
(63%) said yes, three (16%) said no, and four (21%) did
not provide an answer. This ties back into the issue of
awareness of research, and supports the previous com-
ments that communication and awareness has increased,
at least in some clinical areas.
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When asked about barriers to research, four inter-
viewees (21%) mentioned issues of poor awareness:
two (11%) noted that staff do not know what research
opportunities there are, and two more (11%) noted
that the split between the NHS and the University
means that many medical staff do not directly en-
counter research. The interviewees were also asked
whether there are any changes which would enable
more benefit to OUH from research being carried
out, to which five respondents (26%) indicated that
increasing awareness of research among staff would
be beneficial. This would include, they said, informing
staff about how to access research funding, encour-
aging non-researchers to suggest ideas, and feeding
back findings to staff. An additional respondent sug-
gested that a research champion should be introduced
in each Directorate to highlight and promote re-
search. In addition, five interviewees (26%) indicated
that external communication to inform patients and
the public about research should be improved.
Theme 4 – Reputation When asked what the Oxford
BRC brings to the OUH and to patient care, four inter-
viewees (21%) volunteered that the Oxford BRC im-
proves the reputation and profile of OUH. One of them
felt that that the hospital is more likely to attract funding
for improved physical infrastructure because of its high
reputation, and that its high overall reputation is due in
part to its high research reputation. Another explained
that a high research reputation attracts more and better
staff, as there are opportunities for networking, getting
involved in the research programme and publishing.
Reputation therefore also influences staff recruitment
and retention (discussed further below), patient involve-
ment, and access to high quality physical infrastructure.
Reputation per se is not mentioned as a distinct mech-
anism in the Hanney framework, although reputation is
linked to the kinds of access to better infrastructure and
human capital (staff ) that are specified under the first of
the Hanney mechanisms, ‘absorptive capacity’. We con-
sider reputation to be distinct from absorptive capacity.
Reputation is seen from a perspective outside the organ-
isation, in this case OUH, whereas absorptive capacity is
a characteristic of the people who work within the
organisation and of how the organisation is set up.
Theme 5 – Staff recruitment and retention Research
(including that linked to the Oxford BRC) was identified
as a key factor for attracting and retaining high quality
clinical staff (medical and non-medical) to OUH. The
impact on an organisation of being research-active is
mentioned as part of the third item in the Hanney
framework – ‘organisational mechanisms within healthcare
systems’ – but we found it being given rather more promin-
ence than that among the senior OUH clinicians we
interviewed.
When discussing the positive effects of the Oxford
BRC on OUH and patient care, nine interviewees (47%,
including one of the divisional directors who was also an
RT lead) mentioned that the Oxford BRC attracts good
clinical staff to OUH. Two of these respondents added
that, if the Oxford BRC were to be discontinued, staff
members would be lost. This would not just be those
staff members who are funded by the Oxford BRC, but
also staff leaving to pursue research elsewhere. One
interviewee was clear that “research means a great
learning environment” that is attractive to high quality
staff, and another commented that the Oxford BRC is a
“huge benefit to the [OUH] – [the] academic aspect
draws in good people and its culture is appealing”.
It was noted by two interviewees that research as a
lure for high quality clinical staff is particularly im-
portant in Oxford as it is an expensive place to live:
“Oxford is expensive and it’s hard to recruit and re-
tain staff, but doing research makes the job more in-
teresting, gives variety, and it’s something other places
don’t offer”.
However, when discussing the possible challenges for
OUH posed by the Oxford BRC, three interviewees
expressed a concern that some of the best clinical staff
may be attracted away from clinical posts and into re-
search posts (see also Theme 2: formalisation of research
roles). One interviewee explained that staff members
sometimes move to research to get away from the more
stressful environment of the NHS, and another noted
that for doctors, nurses and other professional groups,
moving from clinical work to supporting research
usually means higher pay. In addition, two interviewees
noted the loss of high quality clinical staff into research
posts as a potential downside for patients of staff in-
volvement in research.
Theme 6 – Patient benefits from staff involvement in
research The interviewees were explicitly asked about
benefits and downsides for patients of staff being in-
volved in research. Seventeen of 19 interviewees (89%)
agreed that patients benefit from staff having direct in-
volvement in research. The reasons given included that:
 Staff are better and more informed or interested
(37%), which maps to the ‘absorptive capacity’ and
‘participatory research’ headings in the Hanney
framework
 Patients receive more monitoring and staff contact/
communication (37%), which overlaps with the
Hanney framework’s ‘improvement in the processes
of care related to conducting a specific trial’
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 Patients get access to new treatments (21%), which
is part of the ‘absorptive capacity’ and ‘participatory
research’ categories in the Hanney framework
 Patients evidently appreciate that staff are interested
in the condition they have presented with (21%),
again part of the ‘absorptive capacity’ item in the
Hanney list of mechanisms;
 It seems that patients are themselves better
informed (16%), which can be seen as part of
‘participatory research’ in the Hanney framework
 Patients appear to enjoy contributing (11%), which
is a spin-off from involving more patients in clinical
trials and is not mentioned in the Hanney frame-
work. (One interviewee commented that low drop-
out rates from clinical trials at OUH (described
as less than 5%) indicate high patient satisfaction.
An illustrative example was given by another inter-
viewee of a recent research project which involved
comprehensive interviews with patients and families.
Even the experience of undergoing the interview was
thought likely to have had a positive psychological
impact on the patients interviewed.
Of the two interviewees who indicated that there were
no benefits to patients from staff being involved in re-
search, one stated this was because the staff in their Dir-
ectorate were providing a clinical support service and
did not directly interact with patients. The other consid-
ered that the impact of research on clinical care may
take time to become apparent, and there were no clinical
changes that could be pointed to yet.
A variety of downsides to staff involvement in re-
search were identified, although less frequently than
upsides. Three interviewees (16%) stated that there
were no downsides and another three offered no ex-
amples. However, five interviewees (26%; one of whom
was one of the divisional directors who was also an
RT lead) suggested that patients have to give up more
of their time (although they may not mind and more
contact may be seen as positive); three (16%) that
research puts pressure on scarce space and/or equip-
ment; and two (11%) that good nurses can be lost to
research posts (see also Theme 2, formalisation of
research roles, and Theme 5, staff recruitment and re-
tention). Additional suggestions included unwanted
side effects of novel treatments (e.g. chemotherapy),
the risk of overburdening patients and that not all
patients may be keen to take part.
Theme 7 – Access to infrastructure Interviewees were
asked whether research has meant a change in the infra-
structure at OUH that is available for use in patient care.
This item maps specifically to the first mechanism listed
in the Hanney framework. Overall, 14 interviewees (74%;
which includes both of the divisional directors who were
also RT leads) said the infrastructure for patient care
had been improved as a result of research activity in-
cluding that by Oxford BRC, and five (26%) said it had
not. Examples from the 14 yes-responders included
whole genome sequencing, a digital pathology slide
scanner, the clinical trials aseptic unit, laboratory facil-
ities for flow cytometry, and a large resource centre in-
cluding a library, which was built by the university.
Interestingly, while one interviewee mentioned the AVIC
as an example of additional infrastructure that has be-
come available for patient care, another interviewee said
that they were unable to access the AVIC due to the size
of the usage fees for it.
Of the five interviewees who said no, one commented
that research puts pressure on already scarce space, in
particular on outpatient clinic slots when extra clinics or
longer consultations are required by a research project.
Another observed that, “Generally, research is under-
taken in dedicated research space and has little impact
upon clinical infrastructure”.
Theme 8 – Novel treatments and technologies Seven-
teen interviewees (89%) agreed that OUH being
research-active has helped OUH patients to access novel
technologies, and 16 (84%) agreed that research has led
to more patients going into clinical trials, although three
of these stated that this does not automatically mean
additional benefits for patients. The benefits of a novel
treatment that are captured by the patients who partici-
pate in the clinical trial of that particular treatment are
outside the scope of the Hanney framework. However,
benefits of earlier access to novel technologies, which
are felt by the rest of the hospital’s patients beyond those
taking part in a specific clinical trial, are decidedly
within the Hanney framework as a way in which patient
care is improved in a research-active setting.
Specific examples of novel technologies which have
become available at OUH due to research include (1)
genetics patients getting much broader genetic testing
than they would otherwise have had, leading to diagno-
ses that would not have been possible before, which in
turn leads to more effective treatment; (2) fibroscan test-
ing for liver disease; and (3) a new technique for cardio-
resynchronisation therapy using a lead to pace the left
ventricle of the heart, which is used to treat patients
with heart failure. The new technique involves punctur-
ing the septum (partition of the atria) and fitting the
pacemaker that way.
One interviewee commented that, in addition to
directly benefitting patients, earlier access to novel
treatments and technologies increases clinicians’ aware-
ness and familiarises them with these treatments. This
increases their confidence in asking for and using novel
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medicines for their patients. It also means that other
staff become used to using the novel treatments and
technologies earlier than might be the case in other
hospitals.
Theme 9 – Attitudes to research Attitudes to research
may, as with others of the themes, be seen as an
(important) element of absorptive capacity. Three inter-
viewees (16%) specifically noted that there has been a
culture change at the OUH, as research has become
more ingrained in day-to-day work, and two of these
specifically linked the culture change to the Oxford
BRC. Two further interviewees (11%) noted that staff
often talk about studies and ideas, and a third commen-
ted: “The people are motivated and interested and the
team may be better. When there’s research, there’s more
general interest in what is going on and how to do
things”. Four interviewees (21%) also noted that curiosity
and personal interest are key factors for encouraging
staff involvement in research. These are all aspects of
improved ‘absorptive capacity’.
When asked whether staff have changed in their re-
ceptiveness to learning from research, nine of the 19 in-
terviewees (47%) said yes (two of these nine were the
divisional directors who were also RT leads), one of
whom commented: “The medical teams leading the re-
search are making much bigger efforts to engage the staff
on what they’re doing and there has been greater accept-
ance of research protocols being added to routine clinical
treatment”. Four interviewees (21%) said no, three of
whom elaborated that staff in their part of the OUH
have, in their view, always been receptive to research.
The remaining six interviewees (32%) either did not
answer, or provided mixed or ‘unsure’ responses.
The interviewees were also asked whether research
has encouraged clinicians who are not involved in
research to be more willing to use research findings.
Eight interviewees (42%) answered yes, four (21%) said
no (one of whom noted that this was because they re-
cruit people who already have an interest in research),
and the remaining seven (37%) either did not answer or
provided mixed or ‘unsure’ responses. One interviewee
who said no explained that “Clinicians have always
looked at research. However, the research is now more
readily available”.
Theme 10 – Collaboration Interviewees were specific-
ally asked who OUH staff interact with when conducting
research, and whether there have been changes over
time. Ten of the 19 interviewees (53%) mentioned the
University of Oxford as a key collaborator (this included
the two divisional directors who were also RT leads),
four (21%) mentioned industry, two (11%) mentioned
international collaborators, and one (5%) mentioned
Oxford Brookes University. Six respondents (32%) indi-
cated that there were collaborations with a variety of
organisations.
Few respondents commented on whether or not the
balance between these collaborations had changed over
time. One commented that there had been no change
over time in the collaboration with the University of
Oxford (although it should be noted that this inter-
viewee was much more familiar with the Biomedical
Research Unit at the Nuffield Orthopaedic Centre than
with the Oxford BRC), whereas another commented that
during their time as a consultant there had been a
“steady improvement in NHS/university relations to-
wards more collaboration”.
Collaboration is likely to be closely linked to many of
the other themes that emerged from the interviews with
senior OUH clinicians. Adams [14] describes the bene-
fits of collaborative working as “It provides access to re-
sources, including funding, facilities and ideas”. Increases
in collaboration are likely to influence the amount of re-
search activity (Theme 1), communication and aware-
ness of research (Theme 3), reputation (Theme 4) and
therefore staff retention (Theme 5) and patient benefits
from staff involvement (Theme 6), access to infrastruc-
ture (Theme 7), access to novel treatments (Theme 8),
and attitudes to research (Theme 9).
Individual projects
The interviewees were asked whether they were aware of
any specific Oxford BRC-related projects. Twelve of
them identified one or more specific projects. In all, 24
different projects were mentioned unprompted by at
least one of the clinicians interviewed. We have con-
firmed 16 of these as being Oxford BRC-related projects
(12 of them were in the list of projects suggested by RT/
WG leaders; five of them were mentioned by the
divisional directors who were also RT/WG leaders). One
project (SEND) was mentioned by two different inter-
viewees, and was the only project to receive more than a
single unprompted mention. The senior clinicians identi-
fied 10 of the 16 projects as having had an impact on
patient care at OUH, but in most cases we did not
obtain further details about the type of impact.
When prompted about a set of specific Oxford BRC-
related projects or clinical service initiatives (selected as
most likely relevant to the interviewee from the list of
44 compiled from the RT/WG interviews), interviewees
considered that 11 had had an impact or potential im-
pact on patient care at OUH, making 21 (48%) impactful
BRC projects in total (Table 2). All interviewees said
they were aware of at least one of the projects/initiatives
suggested to them, even if they could not provide further
details about it. Comments made by the interviewees
indicated that they were aware of a range of research
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projects taking place in their Directorate or Division
and involving University collaboration, but they often
did not know which were linked to Oxford BRC.
Unsurprisingly, interviewees were most familiar with
projects they had some direct involvement with.
Cross-analysis of results from RT/WG interviews and senior
clinician interviews
Comparing the comments made by both sets of
interviewees – RT/WG leads and senior clinicians –
allowed us to assess the themes from two different
perspectives and obtain a more complete picture of
the Oxford BRC’s impacts on the OUH. RT/WG
interviewees spoke in depth about the research they
are involved in and often identified a range of
positive impacts of that work, including academic
impacts. The senior clinicians, who are responsible
for managing and delivering clinical services, had a
strong awareness of the practical implications of re-
search activity.
Unsurprisingly, the RT/WG leads expressed predom-
inantly positive views about research in general. The se-
nior clinician interviewees presented a more mixed
picture, although still more often positive rather than
negative about research. Differences in views that arise
tend to reflect the interviewees’ differing roles and re-
sponsibilities. A summary of the overall positive and
negative findings under each theme, with an indication
of which groups of interviewees made the relevant com-
ments, is presented in Table 3.
Interviewees from both groups agreed that there
has been an increase in research activity (Theme 1)
in recent years, although some senior clinician inter-
viewees questioned how clinical areas were chosen to
receive support from the Oxford BRC. RT/WG inter-
viewees indicated that the Oxford BRC has helped to
drive the increase in research by providing research
infrastructure and helping to attract research funding.
They explained that the Oxford BRC had been able
to bring about this change in part because it had
enhanced the reputation of the OUH (Theme 4), a
view that was strongly supported by senior clinician
interviewees. The presence of the Oxford BRC was
widely recognised as a badge of high quality.
RT/WG interviewees thought that the Oxford BRC
had brought about more collaboration between the
OUH and the University of Oxford; however, this
observation was made by relatively few senior clin-
ician interviewees. Some senior clinician interviewees
did report that staff had become more receptive to
and interested in research, a view consistent with
RT/WG interviewees’ comments that research bring-
ing about positive changes in attitudes to research
(Theme 9). A minority of interviewees from both
groups felt that there was still a clear divide between
the two institutions, and between researchers and
non-researchers.
The shift towards formal research roles for clinical
staff was widely discussed by both sets of interviewees
(Themes 2 and 5). RT/WG interviewees emphasised the
positive benefits of protected research time, which
enables clinical staff to engage more in research, and of
support from research nurses. However, senior clinician
interviewees, many of whom were involved in job
planning as part of their clinical roles, observed that it
can be challenging to plan around these posts in the
NHS environment. Multiple senior clinician interviewees
also voiced a concern that nurses and other non-medical
staff are being lured away from clinical work to the
better pay and conditions available in research posts.
Still, both sets of interviewees agreed that the Oxford
BRC, and the Oxford environment more generally, help
to attract high-quality staff.
Comments made by senior clinician interviewees
indicated that research opportunities are not always
being effectively communicated to OUH staff (Theme
3). Although some said improvements had been made
in this area, it was still often cited as an area for
improvement. There was seen to be a need for better
communication about what research is taking place,
as well as an increase in opportunities to get in-
volved. When prompted about specific Oxford BRC
projects and initiatives, senior clinician interviewees
occasionally expressed surprise that projects were
considered ‘Oxford BRC projects’, highlighting some
ambiguity about what it means for a project to be an
Oxford BRC project and, potentially, a need for better
communication about Oxford BRC activities. RT/WG
interviewees, on the other hand, discussed how a
range of opportunities (e.g. for training) were avail-
able and how the Oxford BRC was supporting various
initiatives to encourage researchers’ engagement with
patients and the public.
A range of benefits for patients, including access to
novel treatments and technologies (Theme 8), and infra-
structure (Theme 7), were identified by both groups of
interviewees. However, some senior clinician inter-
viewees commented that research can put extra pressure
on clinical infrastructure and indicated that not all major
equipment is made available for wider use. Senior clin-
ician interviewees in particular discussed other patient
benefits from staff involvement in research (Theme 6),
including patients having more contact with staff and
staff becoming better informed about clinical research
developments. Many of the senior clinicians we inter-
viewed felt that patients enjoy being involved in re-
search, but some acknowledged a risk that patients
could be overburdened by it. Three RT/WG interviewees
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Table 2 The Oxford Biomedical Research Centre (BRC) projects that Research theme/Working group leads indicated had potential
impacts on patient care at Oxford University Hospitals NHS Foundation Trust (OUH), with an indication of whether that impact was
perceived by senior clinicians at OUH
BRC Research theme/
Working group
Oxford BRC projects with potential impact on
patient care
Potential impact on patient
care at OUH
OUH senior clinician
mentioned impact
unprompted?a
OUH senior clinician
confirmed impact
after prompting?a
Biomedical Informatics and
Technology
Gestational diabetes smartphone application Processes and/or service
organisation
YES n.a.
New alerting score based on patients’
vital signs (CALMS-3 Study – Computer
Alerting Monitoring System)
Processes and/or service
organisation
NO NO
Maintenance of database of samples and
consent management for Oxford Biobank
Processes and/or service
organisation
NO YES
System for Electronic Notes Documentation
(SEND) project (electronic track and trigger
and patient alerting)
Processes and/or service
organisation
YES n.a.
Blood Training and hiring staff and improving
infrastructure for clinical programme to do
stem cell transplants and run more clinical
trials in this area
Treatments NO NO
Cancer Multi-gene testing service with rapid
(1 week) turnaround
Diagnostics, testing,
screening
NO YES
BRC-funded clinical research posts specialising in
sarcoma, gynaecological cancers and melanoma
Staffing for specialist
services
NO NO
Cardiovascular MRI diagnostic tools for patients with
intermittent angina
Diagnostics, testing,
screening
NO YES
Clinical Informatics Upgrade for cancer informatics in OUH (enabled
by Genomic Medicine Centre (GMC) designation)
Diagnostics, testing,
screening
NO NO
Molecular diagnostics and genome sequencing
services (enabled by GMC designation)
Diagnostics, testing,
screening
NO NO
Development of integrated logical record
for each cancer patient (in progress)
Processes and/or service
organisation
NO YES
True colours technology for mental health
patients across Oxfordshire to aid self-
management
Processes and/or service
organisation
NO YES
Streamlining management of notes/records from
multidisciplinary cancer meetings (in progress)
Processes and/or service
organisation
NO YES
Clinical decision support dialogue to make
blood orders more efficient
Processes and/or service
organisation
NO NO
Dementia and
Cerebrovascular Disease
New screening process for acute confusion
in medical admissions
Diagnostics, testing,
screening
NO YES
Fast track carotid surgery Treatments NO NO
Telemetric home blood pressure monitoring Processes and/or service
organisation
NO NO
The first transient ischaemic attack (TIA) and
minor stroke clinic in the United Kingdom
Processes and/or service
organisation
YES n.a.
Diabetes Diagnostic programme to identify patients
with a genetic basis for their diabetes
Diagnostics, testing,
screening
NO NO
Pancreatic islet extraction unit Treatments NO NO
Pancreatic transplants Treatments NO NO
Functional Neuroscience
and Imaging
Imaging protocols (epilepsy) Diagnostics, testing,
screening
NO NO
Functional neurosurgery team (part of the
BRC) provides a clinical service, including
pain deep brain stimulation
Treatments NO NO
Specialist clinic in epilepsy, Parkinson’s
disease, motor neurone disease, supported
by BRC-funded research fellows
Staffing for specialist
services
NO NO
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Table 2 The Oxford Biomedical Research Centre (BRC) projects that Research theme/Working group leads indicated had potential
impacts on patient care at Oxford University Hospitals NHS Foundation Trust (OUH), with an indication of whether that impact was
perceived by senior clinicians at OUH (Continued)
Genomic Medicine Targeted next generation sequencing Diagnostics, testing,
screening
NO NO
Whole exome or whole genome sequencing Diagnostics, testing,
screening
NO NO
Immunology and
Inflammation
Non-invasive tests for liver disease Diagnostics, testing,
screening
YES n.a.
Patient stratification for biologic therapies Diagnostics, testing,
screening
NO YES
Tests to diagnose encephalitis (brain
inflammation)
Diagnostics, testing,
screening
NO NO
Trials on treatment of inflammation in eczema Treatments NO NO
Infection Work linking care to outcomes with big
data approaches
Processes and/or service
organisation
NO NO
Genomic testing to support infection
monitoring (provided informally)
Processes and/or service
organisation
NO NO
Molecular Diagnostics Oxford designated as GMC for Genomics
England’s 100,000 Genomes Project
Diagnostics, testing,
screening
YES n.a.
Multi-gene testing for cancer patients Diagnostics, testing,
screening
NO YES
Diagnostic tests for children with rare
blood conditions
Diagnostics, testing,
screening
NO NO
Response prediction in leukaemia Diagnostics, testing,
screening
NO YES
Prevention and
Population Care
The first TIA and minor stroke clinic in the
United Kingdom
Processes and/or service
organisation
YES n.a.
Surgical Innovation and
Evaluation
Chemotherapy (device targeted therapy):
liposomes developed to carry the treatment
to the organ of interest
Treatments NO NO
Image-guided surgery using fluorescents Treatments YES n.a.
Organ transplantation/reconditioning Treatments NO NO
Restoring vision through an electronic implant Treatments YES n.a.
Restoring vision through gene therapy Treatments YES n.a.
Training and Education No projects identified
Translational Physiology No projects identified Diagnostics, testing,
screening
YES n.a.
Vaccines Respiratory syncytial virus, trialling a new
vaccineb
Treatments (national) YES n.a.
Meningitis, looking at trials of schedules
for baby vaccines, booster doses,
meningitis B vaccine trialsb
Processes and/or service
organisation (national)
YES n.a.
Multiple Research themes/
Working groups
Better infrastructure for clinical trials
and other studies (e.g. better
pharmacovigilance, biobanking)
Processes and/or service
organisation
NO YES
NO, Either none of the clinicians interviewed recognised the project as described, or if it was recognised it was not confirmed as having an impact on patient
care; YES, At least one clinician interviewed recognised the project and confirmed impacts from it; n.a., Not applicable
aThe absence of a YES from both of the last two columns of the table should not be interpreted as evidence of an absence of clinical impact. The approach used
to query impacts had limitations. Each interviewee was prompted with a list of 3–6 projects selected by the interviewers before the interview on the basis of the
interviewee’s clinical area, so lack of recognition of projects could result from (1) unsuitable choice of prompts by the interviewers, (2) projects not being used as
prompts, or (3) the projects may not have been described in terms familiar to the interviewees
bProjects were not among those prompted, because their impact is national rather than specific to OUH, but they were both mentioned by clinicians unprompted
In addition to the projects in the table that were mentioned unprompted, four projects were mentioned unprompted and confirmed to be Oxford BRC projects:
digital monitoring of neonates in an intensive care unit, research on radiotherapy for rectal cancer, Tardox project to deliver treatment to specific tumour sites in
liver, and metabolic imaging of brain tumours. A further eight projects were mentioned unprompted by the senior clinicians when asked about Oxford BRC
projects that might have impacted patient care, but these had not been mentioned by the Oxford BRC RT/WG leads and were not identifiable from Oxford BRC
documentation as being projects they had contributed significantly to
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described how clinicians who do research are exposed to
different approaches and reflect more about how to
approach their work.
As mentioned previously, comments made by the two
divisional directors who were also RT/WG leads were
not markedly different from those of the other RT/WG
leads. During the senior clinician interviews, these two
interviewees highlighted many important benefits of the
Oxford BRC. For example, both felt that clinical staff
had become more interested in research over time, both
Table 3 Summary of analysis across Oxford Biomedical Research Centre (BRC) research theme/working group (RT/WG) leads and
Oxford University Hospitals NHS Foundation Trust (OUH) senior clinician (SC) interviews, organised by theme
Theme Positive changes mentioned
(interviewee type)
Challenges and risks mentioned
(interviewee type)
1. Research activity Research activity has increased over time
(SC and RT/WG)
The Oxford BRC plays an important role in
enabling research to happen and helps attract
additional research funding (RT/WG)
For some, it is unclear how decisions are
made about which clinical areas receive
Oxford BRC support (SC)
The types and topics of research taking place
may not fully align with OUH clinical needs (SC)
2. Formalisation of research roles There has been an increase in the number of
medical and non-medical clinical research staff
(SC and RT/WG)
More clinical staff have time protected for
research, which better enables them to
engage in research (SC and RT/WG)
The fixed-term, part-time nature of Oxford
BRC research posts can create tension for
OUH staff organisation and planning (SC)
3. Communication and awareness of research Staff awareness of ongoing research and
associated opportunities has increased in
some clinical areas (SC)
Oxford BRC has increased the profile of
patient engagement in research through
multiple initiatives (RT/WG)
Clinical staff should be better informed about
research taking place, opportunities to get
involved and findings (SC)
External communications could be improved
(SC)
4. Reputation Oxford BRC improves the reputation and
profile of OUH (SC and RT/WG)
None mentioned
5. Staff recruitment and retention Staff are attracted to the OUH because they
believe the Oxford BRC and links to the University
of Oxford will create opportunities for research
and career development (SC and RT/WG)
Research opportunities may encourage staff
not to leave the OUH (SC)
High quality staff (especially non-medical staff)
move into research posts and out of clinical
work (SC mainly, but also RT/WG)
6. Patient benefits from staff involvement in
research
Staff are better informed about developments
in treatments (SC)
Staff reflect more on clinical decisions and
how to deliver care (SC and RT/WG)
Patients interact with staff more; they may
receive better care and feel better cared for (SC)
Patients gain access to new treatments (SC)
Patients report that they enjoy being involved
in research and feel they are contributing to
the public good (SC and RT/WG)
Patients may feel inconvenienced or
overburdened, particularly if study design and
communication to patients are poor (SC)
7. Access to infrastructure Additional, improved or lower-priced infra-
structure has become available in some areas
because of research (SC and RT/WG)
In other areas, there may be opportunities to
share infrastructure which are not being
realised (SC)
Research activity can put additional pressure
on clinical infrastructure (SC)
8. Novel treatments and technologies Many patients have had access (or earlier
access) to novel treatments and technologies
because of research (SC and RT/WG)
None mentioned
9. Attitudes to research In some areas staff have become more
interested, motivated and willing to use
research findings (SC)a
Some perceive a split between the University
and NHS; some staff never engage with
research and may feel ‘outside’ of research (SC
and RT/WG)
10. Collaboration Oxford BRC brought more collaboration
between Oxford University and the OUH; it
made research more clinically relevant and
raised the profile of research in the OUH (RT/
WG mainly, but also SC)
None mentioned
aIn some areas, interest and willingness to use findings has been high for a long time, or has increased through a wider shift towards evidence-based medicine
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felt that there had been benefits to patients of being
included in more trials where they get closer monitoring,
and both felt that staff had increased in their receptive-
ness to learning from research. When asked what would
happen if the Oxford BRC was discontinued, one com-
mented that it would be “tragic, unthinkable, a major
setback”. Perhaps unsurprisingly, these interviewees felt
that more funding and more research would further
benefit OUH.
Fit with the Hanney framework
In our discussion of the themes emerging from the in-
terviews with senior clinicians at OUH, we have noted
the extent to which they relate to the mechanisms listed
in the Hanney framework as possible ways in which re-
search activity at a healthcare provider might affect the
care received by its patients. In the following paragraphs,
we go through each of the Hanney mechanisms in turn,
summarising the extent to which the evidence from the
OUH senior clinician interviews corresponds to them.
Absorptive capacity Interviewees did report improve-
ments in infrastructure (Theme 7), human capital
(Themes 2 and 5) and attitudes towards research
(Theme 9), which have an impact outside of research
activities, i.e. on patient care. Changes in human capital
were mainly linked to improvements in knowledge, mo-
tivation, awareness and attitudes, rather than additional
personnel. The Hanney framework suggests that add-
itional personnel may be brought in to do research and
then remain afterwards to the benefit of patient care, but
this does not appear yet to have been the case at OUH.
However, several interviewees commented on the possible
recruitment advantages of the enhanced reputation that
research activity, including Oxford BRC, brings to OUH.
Improvements in the processes of care related to
conducting a specific trial Twelve of 19 interviewees
(63%) stated that research had beneficially affected the
way that care is delivered. Interviewees also reported
that more patients are being enrolled in clinical trials,
and that research has helped OUH patients to access
novel technologies (Theme 8).
Organisational mechanisms within healthcare systems
Research does appear to have had an influence at the or-
ganisational level. Some interviewees mentioned a culture
change (Theme 9). The organisation of personnel has also
been altered to some extent (through the formalisation of
research roles and protecting some people’s time for re-
search; Theme 2), thereby making the organisation a more
attractive place to work (Theme 6) and enhancing its
reputation (Theme 4). The presence of research has also
encouraged non-research clinicians to be more willing to
use research findings in some, though not all, areas of the
OUH (Theme 9).
However, challenges remain here, as some of the most
experienced clinical staff are then attracted out of clin-
ical posts into research roles, which then may have a
negative impact on human capital and absorptive cap-
acity for patient care.
Collaborative approaches between organisations,
teams and individuals As discussed earlier, collabora-
tive approaches between the University of Oxford and
OUH were important; such collaboration is a require-
ment of BRC-funded research. Alongside this, and
probably at least partly due to collaboration, eight of
19 interviewees (42%) felt that the relevance of re-
search has increased, and only two (11%) felt that the
relevance had not increased. The remaining nine inter-
viewees (47%) provided mixed or unclear responses.
Action and participatory research No interviewee
referred explicitly to ‘action research’ or ‘participatory
research’ as particular ways of conducting research.
These are approaches which involve the participation of
research users in planning, designing and participating
in research [10]. However, increased staff and patient
participation in research was described on numerous
occasions during the interviews. Research activity by
clinical staff has increased (Theme 1, research activity)
and patients were seen as benefiting from that (Theme
6). Further, as mentioned in the discussion of Theme 9,
attitudes to research, 42% of respondents felt that re-
search had encouraged clinicians to be more willing to
use research findings.
Summary with respect to the Hanney framework
All of the five types of mechanisms suggested in the
Hanney framework by which research-active settings
may provide better patient care were evident, at
least to some degree, in the senior clinicians’ re-
sponses. That is particularly true of enhancement
of absorptive capacity (both infrastructure and hu-
man capital), improvements in processes of care
related to conducting specific clinical trials, and
organisational mechanisms within healthcare sys-
tems. Although better collaboration between OUH
and University of Oxford staff was mentioned,
impacts being achieved via collaborative approaches
between them and third party organisations and
networks were not referred to.
The first set of mechanisms categorised by Hanney
et al. [10] as ‘absorptive capacity’ includes both infra-
structure and human capital. The frequency with which
each of these kinds of impacts was mentioned suggests
it may be helpful to separate them. Furthermore, we
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identified impacts from research activity which, while
clearly connected with infrastructure and human capital,
had their impacts on patient care via a more direct route
than by increasing the organisation’s absorptive capacity.
Thus, research activity led to the provision of physical
infrastructure or human capital that was then also avail-
able for patient care activities (as distinct from research
activities) part of the time. Where this was noted, it rep-
resents a benefit to patient care that appears to us to be
quite distinct from the improved ability of OUH and its
staff to also take more advantage of research conducted
elsewhere.
Finally, we consider that the impact of research activity
on OUH’s reputation, which in turn can lead to patient
care benefits, is worthy of explicit mention as an add-
itional item in the list of mechanisms.
Discussion
The care provided by healthcare organisations whose
staff are more active in research may be affected by that
research activity, and these effects may occur indirectly.
That is, they may arise independently of any direct im-
pacts from implementing the outputs of successful re-
search [10, 12, 15]. Hanney et al. [10] provided a five-
point list of mechanisms through which healthcare
might be improved in research-active settings, which we
have labelled ‘the Hanney framework’. We have under-
taken a qualitative analysis of the extent to which a
major NHS hospital foundation trust, OUH, bears out
that view, with particular reference to the research activ-
ity that is related to the Oxford BRC.
The time required for different types of impacts to
occur varies significantly, and this influenced our study.
Given the long and variable time lags between even
translational research – which is the focus of BRCs –
and consequent benefits (if any) directly stemming from
it, it is too early to detect an impact at OUH directly
from the outputs of research projects related to the
Oxford BRC [16]. The potential indirect impacts can be
expected to occur with rather shorter lags, however.
Some of the mechanisms identified by Hanney et al. [10]
could have an almost immediate impact, e.g. benefits to
routine processes spilling over from increased numbers
of clinical trials, though others would only have an
impact over time, e.g. greater receptiveness towards
research findings generally.
The leaders of the RTs and WGs within the Oxford
BRC identified numerous ways in which they expected
Oxford BRC-related research activity might benefit the
care provided by OUH to its patients. Such expectations
are unsurprising. We therefore tested whether the senior
clinicians responsible for patient services in OUH also
detected any such impacts. We simultaneously tested
the applicability of the Hanney framework as a way of
structuring the analysis.
The Oxford BRC is part of the overall medical and
healthcare research portfolio conducted in Oxford. Our
questioning of senior OUH clinicians therefore focused
first on whether they were detecting impacts from re-
search activity in general. We did not ask them to appor-
tion responsibility for any impacts between different
parts of the research portfolio, but we did then test the
extent to which they were aware of how the Oxford
BRC specifically was contributing to the overall research
endeavour visible in OUH. Overall, we found that the
majority of OUH senior clinicians consider there to be
noticeable impacts on patient care as a result of the re-
search activity going on. The impacts they identified
were consistent with those expected by the RT/WG
leads for Oxford BRC. The impacts identified by the se-
nior OUH clinicians are on balance beneficial, although
some negative consequences were identified alongside
the larger number of positive ones. Many of the senior
clinicians interviewed cited particular Oxford BRC-
related research that was impacting the clinical services
for which they were responsible.
The period of operation of the Oxford BRC, since
April 2007, has seen a perceived increase in the quantity
of research activity at OUH, a greater quantity of explicit
research collaboration between the University of Oxford
and the OUH (which is a condition of NIHR BRC fund-
ing), and greater formalisation of who undertakes re-
search. We note that an even distribution of research is
neither expected nor necessarily desirable, as there will
be higher need for research and/or higher potential
returns to research in some areas compared to others.
Findings from the senior clinician interviews suggested
that the increase in research activity at OUH has not
been uniform across all clinical Directorates/Divisions. It
was outside the scope of the present study to assess how
research was distributed by the BRC and how decisions
about research priorities were made, but this is an area
that is worth future consideration and research.
The increased formalisation of research roles is of par-
ticular interest and appeared to create tension in terms
of staff organisation and planning. Its positive conse-
quence is that OUH staff are reporting clearer protec-
tion of work time for research, giving them the ‘head
space’ to think about and pursue research ideas while
continuing to provide patient care with the rest of their
time. Research opportunities have greater profile among
hospital staff. However, these positive outcomes – of a
more formal distinction between those with paid
research time and those without – have the corollary that
some staff feel excluded from research. Interviewees did
not comment on whether this results in a net negative or
a net positive impact on OUH patient care overall.
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Generally, it seems that Oxford BRC and other re-
search activities at the OUH have had a mixed effect on
staff retention and recruitment for patient care. These
factors attract people to work at OUH, but can then also
take them out of clinical work into research posts. It was
suggested that the attractions of, and greater opportunities
for, a research post may lead to the loss of some high qual-
ity nursing staff from patient-facing work. The net impact
of greater research activity making OUH a more attractive
place to work on the one hand, but taking some experi-
enced staff away from NHS work on the other, is unclear
and might be a worthwhile focus of future more detailed
research.
The reputational benefit of being seen as a research ac-
tive hospital, and the contribution of the Oxford BRC to
enhancing that activity and that reputation, came up sev-
eral times. Reputation per se was not included by Hanney
et al. [10] in their framework. It can be seen as underlying
and reinforcing mechanisms included in the framework:
higher reputation institutions may find it easier to recruit
and retain higher quality staff, other things being equal,
and may find it easier to attract further research funds
and associated infrastructure. However, improved reputa-
tion as a result of research activity may also spill over into
greater confidence among the population served by the
hospital that they will receive high quality care when they
are patients there. There may be a reassurance benefit to
patients and the local population in general, in other
words, which makes reputation another medium by which
research activity may translate into patient and population
benefits. Reassurance value is a recognised category of
benefit, but one which is hard to measure and value [17].
The majority of the senior clinicians we interviewed
saw research, including Oxford BRC-related research, as
leading to improved access to physical infrastructure. A
small number noted a downside, however, in the form of
increased research activity, putting greater pressure on
outpatient clinic capacity and throughput. Although
some provision for capital funding was made in the
NIHR’s initial BRC awards in 2007, the rules of further
quinquennial rounds of BRC funding in 2012 (and 2017)
mean that it cannot be used for capital expenses such as
major equipment or buildings, although it can contribute
to the cost of operating the capital equipment/buildings
obtained from other sources of finance. Furthermore, BRC
funding can help to fund other types of infrastructure
such as (non-clinical) support staff.
In general, receptiveness to research among OUH staff
appears to have increased over time, although three of
the senior clinicians interviewed considered that, in their
areas, research receptiveness had always been good.
Awareness among OUH staff of Oxford BRC-related re-
search projects extended to a reasonably large number
of the projects in the current Oxford BRC portfolio (we
note that interviewees’ ability to recognise projects may
have been affected by our choices about which projects
to prompt them on and the descriptions we provided).
Issues of communication and awareness were, how-
ever, a theme across the senior clinician interviews. In-
terviewees stressed the importance of raising awareness
and providing opportunities for staff to participate in re-
search, and five senior clinician interviewees said that in-
creasing awareness among staff of research being carried
out would enable OUH to benefit more from that re-
search. It seems that some Divisions and Directorates at
OUH have already seen improvements in this area, but
others less so. There is room for further improvement in
communication and awareness of research across OUH.
Senior clinicians interviewed suggested that it would be
helpful to inform staff about how to access research
funding, encourage non-researchers to suggest ideas, en-
sure findings are fed back to staff, appoint a research
champion in each directorate to promote research, and
run seminars and display research posters. Five senior
clinician interviewees also indicated that communication
to patients and the public about research should be
improved.
In addition, 17 out of 19 senior clinicians considered
that patients benefit from OUH staff being involved in
research. These two facts combined imply that Oxford
BRC, by increasing research activity, and specifically col-
laborative research activity, can be viewed as making a
significant contribution to improvements in patient care.
A small number of specific examples of novel technolo-
gies becoming available due to research at OUH were
also mentioned (improved genetic testing/diagnosis, fibros-
can test for liver disease, improved cardio-resynchronisation
therapy).
There was also some confirmation that the Oxford
BRC, by the nature of its requirement for collaborative
working between the University of Oxford and OUH,
had led to an improvement in relations between the two
organisations. Collaboration between research and pa-
tient care has a higher profile now than previously and
offers the prospect of better, more relevant and more
readily adopted (locally at least) research, and with no
apparent negative consequences for patient care.
In conducting the study we found the framework pro-
posed by Hanney et al. [10] to be useful and relevant for
structuring the interview protocol and analysing the re-
sponses we obtained. In addition, we would highlight
that infrastructure and human capital created for re-
search can directly benefit patient care as well as doing
so by improving a healthcare provider’s absorptive cap-
acity. Furthermore, the number of references that were
made to the positive impact of research, and of Oxford
BRC funding status for some of that research in particu-
lar, on the OUH’s reputation among staff and patients,
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suggest to us that ‘reputation’ is worthy of inclusion in
an extended taxonomy of mechanisms by which
research-active settings produce greater patient benefits.
The reassurance that they are receiving high quality care,
or will receive that when they need it, contributes to the
wellbeing of the local population and of patients. Staff
morale, and hence performance, are both likely to be en-
hanced by a higher reputation for the organisation they
work in.
Limitations
Our qualitative study suffers from inevitable limitations.
It does not enable the quantitative estimation of the
scale of any net (dis-)benefits on healthcare at OUH of
the Oxford BRC’s research activity. Disentangling the
quantitative impact of the various mechanisms through
which research activity could have indirect impacts from
the many confounding factors would be problematic;
our approach qualitatively attempts such disentangling.
Inevitably, we are exposed to the possibility that inter-
viewees’ responses are affected by incomplete or biased
recall. What was said in the interviews should not be
taken to represent a full statement of all BRC impacts.
We interviewed the RT/WG leads of Oxford BRC, with
the expectation that they might, taken together, tend to
an optimistic view of the impact of their research on
clinical care at OUH. The purpose of the RT/WG leads
was to enable full preparation for the subsequent inter-
views at OUH, but not to be the source of definitive evi-
dence of impact; for that we rely on the evidence of
NHS staff at OUH. As described earlier, we found much
consistency between what OUH senior clinicians told us
and what the Oxford BRC RT/WG leads expected; but
some of the clinicians referred to negative impacts,
which RT/WG leads might not have been aware of and
had not mentioned.
We selected the clinical heads of Directorates and
Divisions as our interview targets at OUH in order to
balance sufficient direct knowledge of the patient care
services being delivered, against being able to cover the
full width of NHS services provided there, within the
constraints of the project budget and timescale, and
being able to tap the knowledge of people with several,
or more, years of experience of working at OUH. Inter-
viewees at OUH knew we were approaching them for a
study funded by a grant from the Oxford BRC, and we
structured the interview protocol in order to prompt
consideration of all mechanisms by which research
might impact, positively or negatively, on patient care.
Thus, the interviewees would have been sensitised to is-
sues about any possible links between research activity,
specifically research activity related to the Oxford BRC,
and patient care. However, we were careful to avoid
leading questions. Further, during the interviews we did
not remind interviewees of any Oxford BRC research
until after we had obtained their views on any impacts
from research.
It may be that, on average, clinicians who are work-
ing in a more research-active setting are likely to be
more favourably disposed to seeing benefits from
working in a research active setting, than would, on
average, clinicians who are working in a less research
active setting. Qualitative analysis in a research-active
setting, such as OUH, cannot avoid that issue. Never-
theless, qualitative analysis in a relatively research-
inactive setting could not be expected to identify the
impacts of research. Future study might therefore be
directed to identifying and then collecting, at the level
of individual patient care services where our qualita-
tive analysis suggests there has been an impact, quan-
titative indicators of impacts on specific patient care
services. Nevertheless, the clinicians we interviewed
proved ready to describe negative impacts as well as
positive, so any potential degree of bias appears likely
to have been subtle rather than crude.
Conclusions
We identified a range of impacts from research on the
provision of patient care at OUH. Indirect impacts,
which are not generally subject to the long time-lags as-
sociated with direct impacts, were particularly notable.
Oxford BRC-related research contributed to those im-
pacts and to the growth in research activity that has
been experienced in general at OUH over recent years:
 Patients have had earlier access to novel treatments
and technologies as a result of research activity
locally
 Research activity has become more formalised in
recent years, bringing advantages from funded
research time for OUH’s NHS staff, but tensions
with those staff who are not so funded
 NHS staff awareness of research appears to be
increasing, though there is still work to be done to
improve communication about research that is
going on, opportunities to get involved, and the
findings that emerge
 The Oxford BRC adds positively to the reputation
of OUH
 Staff recruitment and retention may be improved in
aggregate, though there are local issues with
experienced staff being drawn into research and
away from patient care
 Patient involvement has increased over time,
associated with a major increase in clinical trial
activity at OUH
 Additional physical infrastructure has become
available in some areas, although this is constrained
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by Oxford BRC funds not being allowed to be used
for capital equipment purchases; against that there
were comments to the effect that the demands of
extra research activity involving patients can increase
pressure on NHS care facilities such as space for
outpatient clinics
 In some areas, staff have become more interested in
and receptive to research findings, although in some
areas such interest and receptiveness have been high
for many years
Impacts from research activity on the effectiveness and
efficiency of patient care at local acute hospitals, as
perceived by senior clinicians responsible for delivering
that care, were numerous and usually positive, although
occasionally negative. The senior clinicians made prac-
tical suggestions for improving that impact, for example, by
better communication, and hence awareness, of research.
The taxonomy of mechanisms described by Hanney
et al. [10] provided a helpful basis for conducting the
analysis and categorising the findings. All five of the
categories of benefit in the Hanney framework were
evident in our particular study. Additionally, the im-
pact of research in general and of the Oxford BRC in
particular on the reputation of the healthcare provider
organisation (OUH) seems worthy of distinct consid-
eration in the framework of mechanisms by which
research activity at a provider benefits (or disbenefits)
patients.
Finally, a number of directions for further research
to better understand the impact of research activity on
patient care suggest themselves. Not least, it would be
potentially highly informative to undertake research
with a wider range and greater depth of staff, includ-
ing non-medical staff, who are responsible for provid-
ing care to patients. This could be most practically
done by focusing on a small sample of clinical services.
As well as going into greater depth, it would be in-
formative to research the extent of any spillovers from
OUH to other parts of the local health economy, par-
ticularly primary care and other community based
care. Of equal interest could be prospective analysis,
monitoring research in real time and monitoring care
provision at the same time in the areas where that re-
search activity is expected to impact most. It would
also be helpful to explore how research is prioritised
and distributed by the BRC across different areas and,
potentially, improve transparency and communications
around this in the OUH. Comparison between the ex-
perience of patient care at OUH, at a comparable
research-active Hospital Trust which is not part of an
NIHR BRC, and at a comparable (in terms of service
mix and scale) Hospital Trust that is significantly less
research-active, would also be valuable.
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